These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 34639055)

  • 1. Epoxyeicosatrienoic Acids and Fibrosis: Recent Insights for the Novel Therapeutic Strategies.
    Guan XX; Rao DN; Liu YZ; Zhou Y; Yang HH
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP450 Epoxygenase Metabolites, Epoxyeicosatrienoic Acids, as Novel Anti-Inflammatory Mediators.
    Shi Z; He Z; Wang DW
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epoxyeicosatrienoic acid administration or soluble epoxide hydrolase inhibition attenuates renal fibrogenesis in obstructive nephropathy.
    Noh MR; Jang HS; Salem FE; Ferrer FA; Kim J; Padanilam BJ
    Am J Physiol Renal Physiol; 2023 Feb; 324(2):F138-F151. PubMed ID: 36475868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arachidonic acid cytochrome P450 epoxygenase pathway.
    Spector AA
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S52-6. PubMed ID: 18952572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytochrome P450 epoxygenase pathway regulates the hepatic inflammatory response in fatty liver disease.
    Schuck RN; Zha W; Edin ML; Gruzdev A; Vendrov KC; Miller TM; Xu Z; Lih FB; DeGraff LM; Tomer KB; Jones HM; Makowski L; Huang L; Poloyac SM; Zeldin DC; Lee CR
    PLoS One; 2014; 9(10):e110162. PubMed ID: 25310404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.
    Imig JD
    Adv Pharmacol; 2016; 77():105-41. PubMed ID: 27451096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
    Xu X; Zhang XA; Wang DW
    Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute mercury toxicity modulates cytochrome P450, soluble epoxide hydrolase and their associated arachidonic acid metabolites in C57Bl/6 mouse heart.
    Amara IE; Elshenawy OH; Abdelrady M; El-Kadi AO
    Toxicol Lett; 2014 Apr; 226(1):53-62. PubMed ID: 24472606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of epoxyeicosatrienoic acids in cardiovascular diseases and cardiotoxicity of drugs.
    Zhang Y; Gao L; Yao B; Huang S; Zhang Y; Liu J; Liu Z; Wang X
    Life Sci; 2022 Dec; 310():121122. PubMed ID: 36309225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epoxyeicosatrienoic acid pathway in human health and diseases.
    Bellien J; Joannides R
    J Cardiovasc Pharmacol; 2013 Mar; 61(3):188-96. PubMed ID: 23011468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology.
    Sacerdoti D; Gatta A; McGiff JC
    Prostaglandins Other Lipid Mediat; 2003 Oct; 72(1-2):51-71. PubMed ID: 14626496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA.
    Diani-Moore S; Ma Y; Gross SS; Rifkind AB
    Drug Metab Dispos; 2014 Feb; 42(2):294-300. PubMed ID: 24311719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging, estrogen loss and epoxyeicosatrienoic acids (EETs).
    Lee AR; Pechenino AS; Dong H; Hammock BD; Knowlton AA
    PLoS One; 2013; 8(8):e70719. PubMed ID: 23967089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular pharmacology of epoxyeicosatrienoic acids.
    Pfister SL; Gauthier KM; Campbell WB
    Adv Pharmacol; 2010; 60():27-59. PubMed ID: 21081214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease.
    Elmarakby AA
    Am J Physiol Regul Integr Comp Physiol; 2012 Feb; 302(3):R321-30. PubMed ID: 22116511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.
    Shahabi P; Siest G; Visvikis-siest S
    Drug Metab Rev; 2014 Feb; 46(1):33-56. PubMed ID: 24040964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function.
    Spector AA; Fang X; Snyder GD; Weintraub NL
    Prog Lipid Res; 2004 Jan; 43(1):55-90. PubMed ID: 14636671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of epoxyeicosatrienoic acids in the liver and kidney of cytochrome P450 4F2 transgenic mice.
    Zhang B; Lai G; Liu X; Zhao Y
    Mol Med Rep; 2016 Dec; 14(6):5739-5745. PubMed ID: 27878278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice.
    Zhu Y; Blum M; Hoff U; Wesser T; Fechner M; Westphal C; Gürgen D; Catar RA; Philippe A; Wu K; Bubalo G; Rothe M; Weldon SM; Dragun D; Schunck WH
    PLoS One; 2016; 11(1):e0145645. PubMed ID: 26727266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-dependent expression pattern of cytochrome P450 epoxygenases and soluble epoxide hydrolase in normal human placenta.
    Cizkova K; Tauber Z
    Acta Histochem; 2018 Aug; 120(6):513-519. PubMed ID: 29908721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.